HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Allison J Cowin Selected Research

Therapeutics

1/2022Nanomaterials-based Drug Delivery Approaches for Wound Healing.
1/2021Treatment of murine partial thickness scald injuries with multipotent adult progenitor cells decreases inflammation and promotes angiogenesis leading to improved burn injury repair.
9/2020Mesenchymal Stem Cell Secretome as an Emerging Cell-Free Alternative for Improving Wound Repair.
1/2020Human multipotent adult progenitor cell-conditioned medium improves wound healing through modulating inflammation and angiogenesis in mice.
12/2016Haptotatic Plasma Polymerized Surfaces for Rapid Tissue Regeneration and Wound Healing.
3/2016Native Australian plant extracts differentially induce Collagen I and Collagen III in vitro and could be important targets for the development of new wound healing therapies.
9/2015In vivo delivery of functional Flightless I siRNA using layer-by-layer polymer surface modification.
5/2015Surface engineering of porous silicon to optimise therapeutic antibody loading and release.
1/2015Stem Cells for Cutaneous Wound Healing.
1/2014A novel murine model of hypertrophic scarring using subcutaneous infusion of bleomycin.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Allison J Cowin Research Topics

Disease

42Wounds and Injuries (Trauma)
01/2022 - 06/2003
15Inflammation (Inflammations)
08/2021 - 07/2006
5Neoplasms (Cancer)
12/2021 - 09/2015
5Cicatrix (Scar)
12/2020 - 06/2011
4Infections
09/2021 - 01/2018
3Wound Infection (Wound Infections)
01/2021 - 01/2018
3Blister (Bulla)
01/2019 - 11/2011
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2021 - 11/2015
2Bacterial Infections (Bacterial Infection)
01/2021 - 01/2018
2Burns
01/2021 - 12/2020
2Carcinogenesis
01/2018 - 11/2015
2Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa)
07/2016 - 04/2013
2Hypertrophic Cicatrix (Hypertrophic Scar)
02/2016 - 01/2014
2Keloid
02/2016 - 01/2015
2Rheumatoid Arthritis
05/2015 - 07/2006
2Leg Ulcer
07/2006 - 01/2006
1Neoplasm Metastasis (Metastasis)
12/2021
1Acute Disease
09/2020
1Dermatitis
09/2020
1Tendon Injuries
08/2020
1Lacerations
08/2020
1Atopic Dermatitis (Atopic Eczema)
01/2018
1Sepsis (Septicemia)
01/2018
1Breast Neoplasms (Breast Cancer)
01/2018
1Epidermolysis Bullosa
10/2016
1Skin Diseases (Skin Disease)
03/2016
1Virus Diseases (Viral Diseases)
09/2015
1Uveitis
05/2015

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
12/2021 - 06/2003
10CollagenIBA
09/2021 - 07/2012
8CytokinesIBA
01/2021 - 07/2006
4HydrogelsIBA
09/2021 - 09/2020
4AntibodiesIBA
12/2020 - 01/2013
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2020 - 07/2006
4Neutralizing AntibodiesIBA
01/2017 - 11/2012
3SilverIBA
01/2021 - 01/2013
3IntegrinsIBA
12/2020 - 08/2009
3Small Interfering RNA (siRNA)IBA
08/2020 - 09/2015
3GelsolinIBA
11/2012 - 06/2003
2MethylcholanthreneIBA
12/2021 - 11/2015
2CateninsIBA
12/2021 - 01/2020
2Silver Sulfadiazine (SSD)FDA LinkGeneric
09/2021 - 01/2021
2Interleukin-10 (Interleukin 10)IBA
12/2020 - 01/2018
2Streptozocin (Streptozotocin)FDA Link
08/2020 - 01/2013
2Conditioned Culture MediaIBA
01/2020 - 01/2020
2Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2019
2AutoantibodiesIBA
01/2019 - 01/2018
2Toll-Like Receptors (Toll-Like Receptor)IBA
10/2018 - 01/2013
2Biological ProductsIBA
07/2016 - 01/2015
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
02/2016 - 01/2015
2Transforming Growth Factor beta1 (TGF beta 1)IBA
02/2016 - 01/2008
2Monoclonal AntibodiesIBA
05/2015 - 07/2012
2PaxillinIBA
07/2011 - 06/2003
2Laminin (Merosin)IBA
08/2009 - 03/2006
2Actins (F Actin)IBA
05/2005 - 06/2003
1TalinIBA
12/2021
1Keratin-14 (Keratin 14)IBA
12/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2021
1Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2021
1N-(3-pyridylmethyl)adriamycin (YM 1)IBA
01/2021
1Transforming Growth Factor beta (TGF-beta)IBA
12/2020
1Blocking AntibodiesIBA
12/2020
1Imiquimod (Aldara)FDA LinkGeneric
09/2020
1Granzymes (Granzyme)IBA
09/2020
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
08/2020
1AntigensIBA
08/2020
1Biocompatible Materials (Biomaterials)IBA
07/2020
1Microfilament Proteins (Actin Binding Proteins)IBA
01/2020
1involucrinIBA
01/2020
1Cyclin D1IBA
01/2020
1Staphylococcal Protein A (Protein A)IBA
01/2020
1Filaggrin ProteinsIBA
01/2020
1Aluminum Oxide (Sapphire)IBA
01/2020
1Leucine (L-Leucine)FDA Link
10/2018
1LuciferasesIBA
01/2018
1Ointments (Pastes)IBA
01/2018
1DaptomycinFDA Link
01/2018
1Pharmaceutical PreparationsIBA
01/2018
1DNA (Deoxyribonucleic Acid)IBA
01/2018
1Mupirocin (Bactroban)FDA LinkGeneric
01/2018
1AminesIBA
02/2017
1CarbonIBA
02/2017
1SiliconIBA
01/2017
1Peptide Hydrolases (Proteases)FDA Link
01/2017
1Therapeutic UsesIBA
06/2016
1RNA (Ribonucleic Acid)IBA
02/2016
1CaspasesIBA
11/2015
1Annexin A5IBA
11/2015
1Immunoglobulin G (IgG)IBA
05/2015
1Infliximab (Remicade)FDA Link
05/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2014
1von Willebrand FactorIBA
02/2014
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2014

Therapy/Procedure

12Therapeutics
01/2022 - 01/2008
3Intradermal Injections
08/2021 - 11/2015
1Cell- and Tissue-Based Therapy (Cell Therapy)
08/2021
1Tenotomy
08/2020
1Artificial Skin
07/2020
1Aftercare (After-Treatment)
01/2020
1Home Nursing (Nursing, Home)
10/2016